0001104659-24-063919.txt : 20240521 0001104659-24-063919.hdr.sgml : 20240521 20240521172902 ACCESSION NUMBER: 0001104659-24-063919 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240517 FILED AS OF DATE: 20240521 DATE AS OF CHANGE: 20240521 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Amin Naseem CENTRAL INDEX KEY: 0001646754 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37977 FILM NUMBER: 24970871 MAIL ADDRESS: STREET 1: 53 FRONTAGE ROAD, SUITE 301 CITY: HAMPTON STATE: NJ ZIP: 08827 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: AVADEL PHARMACEUTICALS PLC CENTRAL INDEX KEY: 0001012477 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 000000000 FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: BLOCK 10-1 BLANCHARDSTOWN CORPORATE PARK STREET 2: BALLYCOOLIN CITY: DUBLIN STATE: L2 ZIP: 15 BUSINESS PHONE: 636-449-1830 MAIL ADDRESS: STREET 1: 16640 CHESTERFIELD GROVE ROAD STREET 2: SUITE 200 CITY: CHESTERFIELD STATE: MO ZIP: 63005 FORMER COMPANY: FORMER CONFORMED NAME: FLAMEL TECHNOLOGIES SA DATE OF NAME CHANGE: 19960422 4 1 tm2415004-2_4seq1.xml OWNERSHIP DOCUMENT X0508 4 2024-05-17 0 0001012477 AVADEL PHARMACEUTICALS PLC AVDL 0001646754 Amin Naseem C/O AVADEL PHARMACEUTICALS PLC 10 EARLSFORT TERRACE DUBLIN 2 L2 D02 T380 IRELAND 1 0 0 0 0 Stock Option (Right to Buy) 15.94 2024-05-17 4 A 0 49500 0 A 2034-05-17 Ordinary Shares 49500 49500 D The options become exercisable in three equal annual installments on each of the first three anniversaries following the 5/17/2024 grant date, subject to the Reporting Person's continued service at each such vesting date. /s/ Jerad G. Seurer, as Attorney-in-Fact 2024-05-21